NASDAQ:CHTP (CHTP) (CHTP) Stock Price, News & Analysis → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free CHTP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CHTP) alerts: Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest About (CHTP) Stock (NASDAQ:CHTP)Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.Read More Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest CHTP Stock News HeadlinesNovember 10, 2023 | finance.yahoo.comBrave Healer Productions Announces the Release of The Life-Changing Power of Self-LoveSeptember 20, 2023 | news.yahoo.comExeter Hospital recognized, York Hospital remains in Cigna network: Seacoast health newsMay 8, 2024 | Unstoppable Prosperity (Ad)RSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.July 23, 2023 | investing.comChelsea Therapeutics International (CHTP)June 8, 2023 | msn.comNickelback to play at Thompson-Boling ArenaJune 8, 2023 | msn.comCUBE-SHAPED croissant named the Crubik is the latest take on the croissantApril 8, 2023 | msn.comVIRAL: This college student was about to be late for class—until he saw his professor on the same trainApril 8, 2023 | msn.comVIRAL: This college student was about to be late in class—until he saw his professor on the same trainMay 8, 2024 | Unstoppable Prosperity (Ad)RSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.January 11, 2023 | msn.comThe history of the Ranji Trophy’s female umpires Rathi, Narayanan, and VenugopalanNovember 27, 2022 | msn.comAlabama takes down No. 1 UNC in 4 OT thrillerNovember 1, 2022 | msn.comCapiz flood leaves councilor deadSeptember 8, 2022 | msn.comQueen Elizabeth Has Passed Away at 96June 30, 2022 | bbc.co.ukDiving finals: 10m MenJune 18, 2022 | benzinga.comToyota PriusSee More Headlines Receive CHTP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CHTP) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CHTP CUSIPN/A CIK1333763 Webwww.chelseatherapeutics.com Phone+1-704-3411516FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report CHTP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (CHTP) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CHTP) investors own include (AVNR) (AVNR), LadRx (CYTR), Dynavax Technologies (DVAX), Ariad Pharmaceuticals (ARIA), Avid Bioservices (CDMO), DryShips (DRYS), (GTATQ) (GTATQ), Intel (INTC), Plug Power (PLUG) and Rexahn Pharmaceuticals (REXN). This page (NASDAQ:CHTP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CHTP) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
